Dr, Magda Papadaki, is Associate Director, MSD, Business Strategy and Operations in Regulatory Affairs International. A stem cell and gene therapy scientist by training, combines over a decade in research, with regulatory and business experience in the EU and US. She joined MSD from the Association of British Pharmaceutical Industry (ABPI) where her roles included head of Product & Process Innovation and head of Manufacturing & Innovation. Prior to ABPI, Magdas experience includes roles at Innovate UK, the MIT Center for Biomedical Innovation, as well as country Director, Regulatory Affairs at Novartis for Greece and Cyprus. Her specialization involves the development of adaptive pathways and partnerships to reshape the HA and HTA assessment and adoption of novel treatments and was member of the global consortium developing the Adaptive Pathway paradigm in MIT, Boston, MA. She holds a PhD in Gene Therapy and Stem Cells from the Un. of Athens, Greece, an MPhil in Bioscience Enterprise from the University of Cambridge, UK and MSc in Pharmacology from the University of Oxford, UK.